ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,199, issued on Dec. 9, was assigned to FAES FARMA S.A. (Vizcaya, Spain).
"Pyridopyrimidines as histamine H4-receptor inhibitors" was invented by Gonzalo Hernandez Herrero (Vizcaya, Spain), Neftali Garcia Dominguez (Vizcaya, Spain), Arturo Zazpe Arce (Vizcaya, Spain), Roberto Olivera Tizne (Vizcaya, Spain), Barbara Noverges Pedro (Vizcaya, Spain), Reyes Corcostegui Vivar (Vizcaya, Spain) and Paloma Tato Cerdeiras (Vizcaya, Spain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compounds of formula (I):or pharmaceutically acceptable salts or solvates thereof, to pharmaceutical compositions comprising them and to their use in the ...